Work

Prospective monitoring of prostate specific membrane antigen–positive biochemically recurrent prostate cancer (PSMA+ BCR): Preliminary data from 6-month PSMA follow-up.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.5098

Authors: Ravi Amrit Madan, Melissa Lauren Abel, Esther Mena, Liza Lindenberg, Megan Hausler, Monique Williams, Amy Hankin, Jeanny B. Aragon-Ching, Laura A. Sena, Russell Kent Pachynski, Edwin Melencio Posadas, Helen Moon, Marijo Bilusic, Fatima Karzai, Peter L. Choyke

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Inova Fairfax Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Washington University in St. Louis, Cedars-Sinai Medical Center, Kaiser Permanente, Kaiser Permanente Riverside Medical Center, University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410811682

Cites:

Cited by: 2

Related to: 10